(2S)-2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioic acid-D5; N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butyn-1-yl]benzoyl]-L-glutamic Acid-d5; N-[4-[1-[(2,4-Diamino-6-pteridinyl)methyl]-3-butynyl]benzoyl]-L-glutamic Acid-d5; 10-Propargyl-10-deazaaminopterin-d5; Folotyn-d5; PDX
Pralatrexate-d5 is a fully characterized chemical compound used as a reference standard of API Pralatrexate. The standard offered is compliant with regulatory guidelines. Pralatrexate-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 146464-95-1 (non-d)
